Food

Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology

• By admin
• Mar 10, 2026
• 1 min read
• 4
• 0
• 0

<ul><li>As previously presented, gedatolisib + palbociclib + fulvestrant (gedatolisib triplet) and gedatolisib + fulvestrant (gedatolisib doublet) reduced the risk of disease progression or death ver… [+12436 chars]

• Tags
• #fulvestrant
• #doublet
• #previously
• #disease
• #chars